Post Ranbaxy Laboratories turmoil, US FDA chief to visit India
After imposing a ban on Ranbaxy Laboratories from shipping drugs and raw ingredients from its Toansa plant in Punjab to the US…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pain sensitivity may be influenced by lifestyle and environment, twin study suggests
Pain sensitivity, previously thought to be relatively inflexible, can change as a result of genes being switched on or off by…
HPV vaccine to benefit 206,000 girls with support from GAVI Alliance
10 countries approved in latest round of HPV vaccine demonstration programmes
Venus Remedies receives Indonesian GMP certification for its Baddi unit
The GMP approval will soon pave way for marketing authorizations from Indonesia; Venus expecting registrations for 10 oncology…
3S Simons Security Systems to showcase SECUPRODUCT at Hannover Messe 2014
SECUPRODUCT enables the direct security of products, parts and components in mechanical and plant engineering as well as in the…
Cell division finding could boost understanding of cancer
Researchers at the University of Edinburgh have pinpointed the key role played by a protein in ensuring that cells separate…
NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes
The M-PACT trial is one of the first to use a randomised trial design to assess if assigning treatment based on genetic screening…
Suven Life Sciences posts PAT of Rs 364 million in Q3 ending December 2013
Suven Life Sciences has announced its un-audited financial results for the quarter ended December 31, 2013
Mylan launches first trastuzumab biosimilar, Hertraz, in India
Is indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths